Advancements in the diagnostic approach to Alzheimer's disease

Alzheimer's disease is recognized as the primary cause of dementia, characterized by a progressive decline in memory, cognitive function, and daily autonomy. Early warning signs often include the repetition of questions, challenges in recalling recent events, difficulty finding words, and struggles with performing familiar tasks, all of which warrant specialized medical evaluation.

The diagnostic landscape for Alzheimer's has undergone a significant transformation in recent years. While clinical symptoms and cognitive assessments remain foundational, diagnosis can now be supported by the identification of specific biological markers. The pathology is primarily driven by two proteins: beta-amyloid, which forms plaques in the brain, and tau, which accumulates within neurons. These processes are directly linked to neuronal dysfunction and the gradual loss of brain cells.

Modern medicine now allows for the detection of these pathological proteins through advanced biomarkers found in blood or cerebrospinal fluid, as well as specialized imaging. This biological approach enables a more precise diagnosis, moving beyond simple clinical observation toward targeted, evidence-based medical assessment.